-+ 0.00%
-+ 0.00%
-+ 0.00%
AB&B Bio-Tech Q3 2026 Net Profit Rises 16% to RMB 59 Million; Revenue Climbs to RMB 322 Million
Share
Listen to the news
AB&B Bio-Tech Q3 2026 Net Profit Rises 16% to RMB 59 Million; Revenue Climbs to RMB 322 Million
  • AB&B Bio-Tech’s third-quarter 2026 net profit rose 16% year over year to approximately RMB 59 million.
  • Revenue increased year over year to approximately RMB 322 million.
  • Profit growth benefited from higher capacity utilization and lower administrative and research and development expenses.
  • Trading in its H Shares remains suspended until further notice, following the suspension effective April 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261117-12415958), on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending